Current and completed investments

Lipigon develops orphan drugs for illnesses due to disorders in how the body handles fat. The company’s major program, Lipsense, focuses on the illness, HoFH, where there is, today, no sufficient treatment.

Likvor offers a CE-certified system helping healthcare personnel to diagnose normal pressure hydrocephalus (NPH) which is a very under diagnosed condition with dementia-like symptoms.

Each year, more than 10 million people suffer from tuberculosis. EMPE has developed a patented quick test for the diagnosis of tuberculosis adapted to clinics with limited resources.

1928 Diagnostics is fighting against the global threat of resistant bacteria by offering software for the quick and effective diagnose of bacterial infections. The software is offered as a software-as-a-service and in combination with hardware already used in hospitals it provided detailed information regarding bacteria and their resistance profiles.